Gynecology and Minimally Invasive Therapy

REVIEW ARTICLE
Year
: 2018  |  Volume : 7  |  Issue : 2  |  Page : 47--55

Outcome and management of uterine leiomyosarcoma treated following surgery for presumed benign disease: Review of literature


Tanitra Tantitamit1, Kuan-Gen Huang2, Manatsawee Manopunya3, Chih-Feng Yen2 
1 Department of Obstetrics and Gynecology, Faculty of Medicine, Srinakharinwirot University, Nakhonnayok, Thailand
2 Department of Obstetrics and Gynecology, Linkou Chang Gung Memorial Hospital; Department of Obstetrics and Gynecology, Chang Gung University College of Medicine, Tao-Yuan, Taiwan
3 Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Correspondence Address:
Dr. Chih-Feng Yen
No.5, Fuxing St., Guishan Dist., Taoyuan City 33305
Taiwan

Uterine leiomyosarcoma (uLMS) is a rare and aggressive cancer, usually diagnosed incidentally at the time of myomectomy or hysterectomy. There have been concerns for several years about the fact that the inadvertent disruption of occult uLMS may have a negative impact on patient outcome. This study reviews the outcome and management of patients with a diagnosis of uLMS after surgery for presumed benign disease. We conducted a literature search in which 47 published English-language articles were obtained for evaluation. A total of 23 studies with outcomes data were included. It is evidenced that patients who underwent surgery with tumor disruption resulted in poorer outcomes compared with en bloc tumor, especially by power morcellation. The power morcellation was associated with an increased risk of recurrence, shorten time to recurrence, and upstage after re-exploration. Early re-exploration and surgical staging are appreciated for better prognosis and may alter postoperative treatment. We also updated on the incidence and preoperative evaluation to assess the risk of patient and give an effective counseling.


How to cite this article:
Tantitamit T, Huang KG, Manopunya M, Yen CF. Outcome and management of uterine leiomyosarcoma treated following surgery for presumed benign disease: Review of literature.Gynecol Minim Invasive Ther 2018;7:47-55


How to cite this URL:
Tantitamit T, Huang KG, Manopunya M, Yen CF. Outcome and management of uterine leiomyosarcoma treated following surgery for presumed benign disease: Review of literature. Gynecol Minim Invasive Ther [serial online] 2018 [cited 2020 Feb 27 ];7:47-55
Available from: http://www.e-gmit.com/article.asp?issn=2213-3070;year=2018;volume=7;issue=2;spage=47;epage=55;aulast=Tantitamit;type=0